Bosutinib in Adult Patients With Recurrent Glioblastoma
Condition(s):GlioblastomaLast Updated:July 25, 2016Completed
Hide Studies Not Open or Pending
Condition(s):GlioblastomaLast Updated:July 25, 2016Completed
Condition(s):Healthy ParticipantsLast Updated:February 11, 2022Completed
Condition(s):Chronic Myeloblastic LeukaemiaLast Updated:April 29, 2020Completed
Condition(s):Blasts Under 15 Percent of Bone Marrow Nucleated Cells; Blasts Under 15 Percent of Peripheral Blood White Cells; Blasts Under 30 Percent of Bone Marrow Nucleated Cells; Blasts Under 30 Percent of Peripheral Blood White Cells; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveLast Updated:May 11, 2020Terminated
Condition(s):B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Blasts More Than 5 Percent of Bone Marrow Nucleated Cells; CD22 Positive; Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia; Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Refractory Chronic Myelogenous Leukemia, BCR-ABL1 PositiveLast Updated:July 17, 2023Completed
Condition(s):Chronic Myelogenous LeukemiaLast Updated:February 6, 2024Recruiting
Condition(s):Accelerated Phase Chronic Myelogenous Leukemia (CML); Blast Phase Chronic Myelogenous Leukemia (CML); Chronic Phase Phase Chronic Myelogenous Leukemia (CML); Philadelphia Chromosome Positive (Ph+) Phase Chronic Myelogenous Leukemia (CML)Last Updated:November 19, 2020Terminated
Condition(s):Previously Treated PH + CMLLast Updated:December 30, 2021Terminated
Condition(s):Philadelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia (CML)Last Updated:November 30, 2011Completed
Condition(s):HealthyLast Updated:October 31, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.